Glaukos
  • HOME
  • ABOUT GLAUKOS
    • HISTORY
    • LEADERSHIP TEAM
    • CAREERS
    • CONTACT US
    • TECHNOLOGY OVERVIEW
  • PHYSICIANS
    • SCIENTIFIC ADVISORY BOARD
    • SCIENTIFIC MEETINGS
    • INTERNATIONAL
    • PHYSICIAN LOGIN
  • INVESTORS
    • BOARD OF DIRECTORS
    • LEADERSHIP TEAM
    • SCIENTIFIC ADVISORY BOARD
    • NEWS
  • PATIENTS
    • GLAUCOMA OVERVIEW
    • RISK FACTORS
    • SYMPTOMS
    • DIAGNOSIS
    • TREATMENT OPTIONS
  • CONTACT US
  • PHYSICIAN LOGIN

Site map

Primary links

  • HOME
  • ABOUT GLAUKOS
    • HISTORY
    • LEADERSHIP TEAM
    • CAREERS
    • CONTACT US
    • TECHNOLOGY OVERVIEW
  • PHYSICIANS
    • SCIENTIFIC ADVISORY BOARD
    • SCIENTIFIC MEETINGS
    • INTERNATIONAL
    • PHYSICIAN LOGIN
  • INVESTORS
    • BOARD OF DIRECTORS
    • LEADERSHIP TEAM
    • SCIENTIFIC ADVISORY BOARD
    • NEWS
  • PATIENTS
    • GLAUCOMA OVERVIEW
    • RISK FACTORS
    • SYMPTOMS
    • DIAGNOSIS
    • TREATMENT OPTIONS
  • CONTACT US
  • PHYSICIAN LOGIN
  • Glaukos Corporation
  • 949.367.9600
  • 26051 Merit Circle, Suite 103, Laguna Hills, CA 92653
  • Site map
  • Terms of Use
  • Privacy Policy

  • ©Glaukos Corporation. All rights reserved. 2009.


  • The U.S. Food and Drug Administration (FDA) has not approved the iStent® Trabecular Micro-Bypass for commercial use. The iStent® Trabecular Micro-Bypass is an investigational device in the United States.